Evidence map›Paper›PMID 24011029›Full record

ArticleAnalytical chemistry2013

Measurement of DNA concentration as a normalization strategy for metabolomic data from adherent cell lines.

Leslie P Silva, Philip L Lorenzi, Preeti Purwaha, Valeda Yong, David H Hawke, John N Weinstein

Abstract read
In one paragraph

Article in Analytical chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Article
  2. Metabolomics: Fundamentals, Methods, Analysis, Limits, and Recommendations.Advances in experimental medicine and biology · 2026
    Review
  3. Mass Spectrometry as a Tool for Metabolomics in Cancer.Advances in experimental medicine and biology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Journal of Cancer · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Advances in Microbial NMR Metabolomics.Advances in experimental medicine and biology · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Leslie P Silva *Department of Bioinformatics & Computational Biology, University of Texas MD Anderson Cancer Center, 1400 Pressler St., Houston, TX, 77030, United States.
Philip L Lorenzi *Department of Bioinformatics & Computational Biology, University of Texas MD Anderson Cancer Center, 1400 Pressler St., Houston, TX, 77030, United States.
Preeti PurwahaDepartment of Bioinformatics & Computational Biology, University of Texas MD Anderson Cancer Center, 1400 Pressler St., Houston, TX, 77030, United States.
Valeda YongDepartment of Bioinformatics & Computational Biology, University of Texas MD Anderson Cancer Center, 1400 Pressler St., Houston, TX, 77030, United States.
David H HawkeDepartment of Pathology, University of Texas MD Anderson Cancer Center, 7435 Fannin St., Houston, TX, 77054, United States.
John N WeinsteinDepartment of Bioinformatics & Computational Biology, University of Texas MD Anderson Cancer Center, 1400 Pressler St., Houston, TX, 77030, United States.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
UNIVERSITY OF TEXAS MD ANDERSON SPORE IN OVARIAN CANCERP50CA083639 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BAST, ROBERT C · 1999 to 2015
$33.0M
Integrative Pipeline for Analysis & Translational Application of TCGA Data (GDAC)U24CA143883 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AKBANI, REHAN, MILLS, GORDON B. · 2009 to 2016
$10.6M
NCI NIH HHS CA083639,NCI NIH HHS CA143883NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA083639NCI NIH HHS U24 CA143883
6 · The paper itself

Abstract

Metabolomics is a rapidly advancing field, and much of our understanding of the subject has come from research on cell lines. However, the results and interpretation of such studies depend on appropriate normalization of the data; ineffective or poorly chosen normalization methods can lead to frankly erroneous conclusions. That is a recurrent challenge because robust, reliable methods for normalization of data from cells have not been established. In this study, we have compared several methods for normalization of metabolomic data from cell extracts. Total protein concentration, cell count, and DNA concentration exhibited strong linear correlations with seeded cell number, but DNA concentration was found to be the most generally useful method for the following reasons: (1) DNA concentration showed the greatest consistency across a range of cell numbers; (2) DNA concentration was the closest to proportional with cell number; (3) DNA samples could be collected from the same dish as the metabolites; and (4) cell lines that grew in clumps were difficult to count accurately. We therefore conclude that DNA concentration is a widely applicable method for normalizing metabolomic data from adherent cell lines.

Indexed as

Cell AdhesionCell CountCell Line, TumorDNAHumansLinear ModelsMetabolomicsTime FactorsDNA

Identifiers

PMID24011029
PMCPMC3868625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.